Chlordiazepoxide Hydrochloride And Clidinium Bromide Capsule
Product Images NDC 11534-197

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Chlordiazepoxide Hydrochloride And Clidinium Bromide (NDC 11534-197). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sunrise Pharmaceutical, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 100

Label for Chlordiazepoxide Hydrochloride and Clidinium Bromide Capsules, USP, 5 mg / 2.5 mg, oral dosage form. The label indicates a package size of 100 capsules. It includes the NDC 11534-197-01 and is manufactured by Sunrise Pharmaceutical, Inc. in Rahway, NJ. Storage and dispensing instructions are also provided.*

FDA Label Image

Structure Chlordiazepoxide

Chemical structure of Chlordiazepoxide Hydrochloride depicting its molecular arrangement including a chlorine-substituted benzene ring and related chemical groups, along with the hydrochloride component.*

FDA Label Image

Structure Clidinium

Chemical structure of Clidinium Bromide, part of the active ingredients in Chlordiazepoxide Hydrochloride and Clidinium Bromide capsules by Sunrise Pharmaceutical, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.